Halogen Interactions in Protein-Ligand Complexes: Implications of Halogen Bonding for Rational Drug Design
暂无分享,去创建一个
Suman Sirimulla | Rahulsimham Vegesna | Mahesh Narayan | Jake B. Bailey | Rahulsimham Vegesna | M. Narayan | J. Bailey | Suman Sirimulla
[1] William J. Welsh,et al. Halogenated ligands and their interactions with amino acids: implications for structure-activity and structure-toxicity relationships. , 2008, Journal of molecular graphics & modelling.
[2] Patric Schyman,et al. Treatment of Halogen Bonding in the OPLS-AA Force Field; Application to Potent Anti-HIV Agents. , 2012, Journal of chemical theory and computation.
[3] Markus O. Zimmermann,et al. Using halogen bonds to address the protein backbone: a systematic evaluation , 2012, Journal of Computer-Aided Molecular Design.
[4] Nahid M. Yazdani,et al. Discovery of inducible nitric oxide synthase (iNOS) inhibitor development candidate KD7332, part 1: Identification of a novel, potent, and selective series of quinolinone iNOS dimerization inhibitors that are orally active in rodent pain models. , 2009, Journal of medicinal chemistry.
[5] Timothy Clark,et al. Halogen bonding: the σ-hole , 2007 .
[6] A. Joerger,et al. Principles and applications of halogen bonding in medicinal chemistry and chemical biology. , 2013, Journal of medicinal chemistry.
[7] Timothy Clark,et al. σ‐Holes , 2012 .
[8] W. Delano. The PyMOL Molecular Graphics System , 2002 .
[9] J. Thornton,et al. Satisfying hydrogen bonding potential in proteins. , 1994, Journal of molecular biology.
[10] P Shing Ho,et al. Halogen bonds as orthogonal molecular interactions to hydrogen bonds. , 2009, Nature chemistry.
[11] Pierangelo Metrangolo,et al. Halogen bonding in halocarbon-protein complexes: a structural survey. , 2011, Chemical Society reviews.
[12] Markus O. Zimmermann,et al. Halogen-Enriched Fragment Libraries as Leads for Drug Rescue of Mutant p53 , 2012, Journal of the American Chemical Society.
[13] Marcelo Zaldini Hernandes,et al. Halogen atoms in the modern medicinal chemistry: hints for the drug design. , 2010, Current drug targets.
[14] Weiliang Zhu,et al. Halogen bonding--a novel interaction for rational drug design? , 2009, Journal of medicinal chemistry.
[15] Weiliang Zhu,et al. Utilization of halogen bond in lead optimization: a case study of rational design of potent phosphodiesterase type 5 (PDE5) inhibitors. , 2011, Journal of medicinal chemistry.
[16] Yong-Jun Jiang,et al. Ab initio investigation of the complexes between bromobenzene and several electron donors: some insights into the magnitude and nature of halogen bonding interactions. , 2007, The journal of physical chemistry. A.
[17] William L Jorgensen,et al. Computationally-guided optimization of a docking hit to yield catechol diethers as potent anti-HIV agents. , 2011, Journal of medicinal chemistry.
[18] William L. Jorgensen,et al. Journal of Chemical Information and Modeling , 2005, J. Chem. Inf. Model..
[19] T. Row,et al. Halogen bonding in fluorine: experimental charge density study on intermolecular F···F and F···S donor-acceptor contacts. , 2013, Chemical communications.
[20] Christophe Meyer,et al. Crystal structures for HIV-1 reverse transcriptase in complexes with three pyridinone derivatives: a new class of non-nucleoside inhibitors effective against a broad range of drug-resistant strains. , 2005, Journal of medicinal chemistry.
[21] Timothy Clark,et al. Halogen bonding: an electrostatically-driven highly directional noncovalent interaction. , 2010, Physical chemistry chemical physics : PCCP.
[22] Weiliang Zhu,et al. The nature and magnitude of specific halogen bonds between iodo‐perfluorobenzene and heterocyclic systems , 2011 .
[23] Eric Westhof,et al. Halogen bonds in biological molecules. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[24] Pierangelo Metrangolo,et al. Halogen Bonding in Halocarbon—Protein Complexes: A Structural Survey , 2011 .
[25] Damian Szklarczyk,et al. Specific CLK Inhibitors from a Novel Chemotype for Regulation of Alternative Splicing , 2011, Chemistry & biology.
[26] Peter Politzer,et al. An overview of halogen bonding , 2007, Journal of molecular modeling.
[27] R. Baldwin,et al. Substituent effects of N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamides on positive allosteric modulation of the metabotropic glutamate-5 receptor in rat cortical astrocytes. , 2006, Journal of medicinal chemistry.
[28] François Diederich,et al. Systematic investigation of halogen bonding in protein-ligand interactions. , 2011, Angewandte Chemie.
[29] S. Withers,et al. A new generation of specific Trypanosoma cruzi trans-sialidase inhibitors. , 2008, Angewandte Chemie.
[30] Stefan Güssregen,et al. Evidence for C-Cl/C-Br...pi interactions as an important contribution to protein-ligand binding affinity. , 2009, Angewandte Chemie.
[31] Timothy Clark,et al. σ-Holes: σ-Holes , 2013 .
[32] Maurizio Sironi,et al. Halogen bonding in ligand-receptor systems in the framework of classical force fields. , 2011, Physical chemistry chemical physics : PCCP.